A citation-based method for searching scientific literature

Elizabeth M Brunt, Vincent W-S Wong, Valerio Nobili, Christopher P Day, Silvia Sookoian, Jacquelyn J Maher, Elisabetta Bugianesi, Claude B Sirlin, Brent A Neuschwander-Tetri, Mary E Rinella. Nat Rev Dis Primers 2015
Times Cited: 385







List of co-cited articles
518 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Zobair M Younossi, Aaron B Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Hepatology 2016
21

Mechanisms of NAFLD development and therapeutic strategies.
Scott L Friedman, Brent A Neuschwander-Tetri, Mary Rinella, Arun J Sanyal. Nat Med 2018
17

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Elena Buzzetti, Massimo Pinzani, Emmanuel A Tsochatzis. Metabolism 2016
14

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
David E Kleiner, Elizabeth M Brunt, Mark Van Natta, Cynthia Behling, Melissa J Contos, Oscar W Cummings, Linda D Ferrell, Yao-Chang Liu, Michael S Torbenson, Aynur Unalp-Arida,[...]. Hepatology 2005
13

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Naga Chalasani, Zobair Younossi, Joel E Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A Harrison, Elizabeth M Brunt, Arun J Sanyal. Hepatology 2018
12

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Zobair Younossi, Quentin M Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Nat Rev Gastroenterol Hepatol 2018
12

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.
Mohammed Eslam, Arun J Sanyal, Jacob George. Gastroenterology 2020
841
12

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
Stefano Romeo, Julia Kozlitina, Chao Xing, Alexander Pertsemlidis, David Cox, Len A Pennacchio, Eric Boerwinkle, Jonathan C Cohen, Helen H Hobbs. Nat Genet 2008
11

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Mohammed Eslam, Philip N Newsome, Shiv K Sarin, Quentin M Anstee, Giovanni Targher, Manuel Romero-Gomez, Shira Zelber-Sagi, Vincent Wai-Sun Wong, Jean-François Dufour, Jörn M Schattenberg,[...]. J Hepatol 2020
912
9

Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.
Chrysi Koliaki, Julia Szendroedi, Kirti Kaul, Tomas Jelenik, Peter Nowotny, Frank Jankowiak, Christian Herder, Maren Carstensen, Markus Krausch, Wolfram Trudo Knoefel,[...]. Cell Metab 2015
475
7

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
Jérôme Boursier, Olaf Mueller, Matthieu Barret, Mariana Machado, Lionel Fizanne, Felix Araujo-Perez, Cynthia D Guy, Patrick C Seed, John F Rawls, Lawrence A David,[...]. Hepatology 2016
625
7

Mechanisms of hepatic stellate cell activation.
Takuma Tsuchida, Scott L Friedman. Nat Rev Gastroenterol Hepatol 2017
7

From NASH to HCC: current concepts and future challenges.
Quentin M Anstee, Helen L Reeves, Elena Kotsiliti, Olivier Govaere, Mathias Heikenwalder. Nat Rev Gastroenterol Hepatol 2019
459
7


The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Konstantin Kazankov, Simon Mark Dahl Jørgensen, Karen Louise Thomsen, Holger Jon Møller, Hendrik Vilstrup, Jacob George, Detlef Schuppan, Henning Grønbæk. Nat Rev Gastroenterol Hepatol 2019
306
7

Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.
Jonathan Chung-Fai Leung, Thomson Chi-Wang Loong, Jeremy Lok Wei, Grace Lai-Hung Wong, Anthony Wing-Hung Chan, Paul Cheung-Lung Choi, Sally She-Ting Shu, Angel Mei-Ling Chim, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong. Hepatology 2017
175
6

Triggering and resolution of inflammation in NASH.
Susanne Schuster, Daniel Cabrera, Marco Arrese, Ariel E Feldstein. Nat Rev Gastroenterol Hepatol 2018
296
6



Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease.
Carlos Jose Pirola, Tomas Fernández Gianotti, Adriana Laura Burgueño, Manuel Rey-Funes, Cesar Fabian Loidl, Pablo Mallardi, Julio San Martino, Gustavo Osvaldo Castaño, S Sookoian. Gut 2013
219
5

Genetics and epigenetics of NAFLD and NASH: Clinical impact.
Mohammed Eslam, Luca Valenti, Stefano Romeo. J Hepatol 2018
384
5

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Zobair M Younossi, Pegah Golabi, Leyla de Avila, James Minhui Paik, Manirath Srishord, Natsu Fukui, Ying Qiu, Leah Burns, Arian Afendy, Fatema Nader. J Hepatol 2019
550
5

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
Robert J Wong, Maria Aguilar, Ramsey Cheung, Ryan B Perumpail, Stephen A Harrison, Zobair M Younossi, Aijaz Ahmed. Gastroenterology 2015
5

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, Heike Bantel, Stefano Bellentani, Joan Caballeria, Massimo Colombo, Antonio Craxi, Javier Crespo, Christopher P Day,[...]. J Hepatol 2018
563
5

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.
Siddharth Singh, Alina M Allen, Zhen Wang, Larry J Prokop, Mohammad H Murad, Rohit Loomba. Clin Gastroenterol Hepatol 2015
803
5


The role of the gut microbiota in NAFLD.
Christopher Leung, Leni Rivera, John B Furness, Peter W Angus. Nat Rev Gastroenterol Hepatol 2016
426
5

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.
Chris Estes, Homie Razavi, Rohit Loomba, Zobair Younossi, Arun J Sanyal. Hepatology 2018
821
5

Noninvasive biomarkers in NAFLD and NASH - current progress and future promise.
Vincent Wai-Sun Wong, Leon A Adams, Victor de Lédinghen, Grace Lai-Hung Wong, Silvia Sookoian. Nat Rev Gastroenterol Hepatol 2018
236
5

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
Paul Angulo, David E Kleiner, Sanne Dam-Larsen, Leon A Adams, Einar S Bjornsson, Phunchai Charatcharoenwitthaya, Peter R Mills, Jill C Keach, Heather D Lafferty, Alisha Stahler,[...]. Gastroenterology 2015
5

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.
Quentin M Anstee, Giovanni Targher, Christopher P Day. Nat Rev Gastroenterol Hepatol 2013
991
5

NAFLD: a multisystem disease.
Christopher D Byrne, Giovanni Targher. J Hepatol 2015
5

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.
Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stål, Stergios Kechagias, Rolf Hultcrantz. Hepatology 2015
5

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
Giovanni Targher, Christopher P Day, Enzo Bonora. N Engl J Med 2010
5

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort.
Quentin M Anstee, Rebecca Darlay, Simon Cockell, Marica Meroni, Olivier Govaere, Dina Tiniakos, Alastair D Burt, Pierre Bedossa, Jeremy Palmer, Yang-Lin Liu,[...]. J Hepatol 2020
127
5


Treatment of NAFLD with diet, physical activity and exercise.
Manuel Romero-Gómez, Shira Zelber-Sagi, Michael Trenell. J Hepatol 2017
490
4

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
G Marchesini, M Brizi, G Bianchi, S Tomassetti, E Bugianesi, M Lenzi, A J McCullough, S Natale, G Forlani, N Melchionda. Diabetes 2001
4

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.
Eduardo Vilar-Gomez, Yadina Martinez-Perez, Luis Calzadilla-Bertot, Ana Torres-Gonzalez, Bienvenido Gra-Oramas, Licet Gonzalez-Fabian, Scott L Friedman, Moises Diago, Manuel Romero-Gomez. Gastroenterology 2015
976
4

Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter.
Silvia Sookoian, Maria Soledad Rosselli, Carolina Gemma, Adriana L Burgueño, Tomas Fernández Gianotti, Gustavo O Castaño, Carlos J Pirola. Hepatology 2010
203
4

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
A J Sanyal, C Campbell-Sargent, F Mirshahi, W B Rizzo, M J Contos, R K Sterling, V A Luketic, M L Shiffman, J N Clore. Gastroenterology 2001
4

Microbial ecology: human gut microbes associated with obesity.
Ruth E Ley, Peter J Turnbaugh, Samuel Klein, Jeffrey I Gordon. Nature 2006
4


Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.
Judith Aron-Wisnewsky, Chloé Vigliotti, Julia Witjes, Phuong Le, Adriaan G Holleboom, Joanne Verheij, Max Nieuwdorp, Karine Clément. Nat Rev Gastroenterol Hepatol 2020
211
4

Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Ivana Mikolasevic, Tajana Filipec-Kanizaj, Maja Mijic, Ivan Jakopcic, Sandra Milic, Irena Hrstic, Nikola Sobocan, Davor Stimac, Patrizia Burra. World J Gastroenterol 2018
65
6

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.
Lixin Zhu, Susan S Baker, Chelsea Gill, Wensheng Liu, Razan Alkhouri, Robert D Baker, Steven R Gill. Hepatology 2013
871
4

NAFLD in children: new genes, new diagnostic modalities and new drugs.
Valerio Nobili, Anna Alisi, Luca Valenti, Luca Miele, Ariel E Feldstein, Naim Alkhouri. Nat Rev Gastroenterol Hepatol 2019
109
4

Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Guillaume Lassailly, Robert Caiazzo, David Buob, Marie Pigeyre, Hélène Verkindt, Julien Labreuche, Violeta Raverdy, Emmanuelle Leteurtre, Sébastien Dharancy, Alexandre Louvet,[...]. Gastroenterology 2015
418
4

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.
Kouichi Miura, Hirohide Ohnishi. World J Gastroenterol 2014
196
4

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
Michael R Charlton, Justin M Burns, Rachel A Pedersen, Kymberly D Watt, Julie K Heimbach, Ross A Dierkhising. Gastroenterology 2011
794
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.